Key result
The C282Y mutation was associated with nonalcoholic fatty liver disease in Iranian patients with type 2 diabetes, whereas the H63D mutation showed no such association.
Why the study?
Are HFE gene variants H63D and C282Y associated with NAFLD in Iranian patients with type 2 diabetes?
Case-Control (n=290)
Are HFE gene variants H63D and C282Y associated with NAFLD in Iranian patients with type 2 diabetes?
The C282Y mutation of the HFE gene may serve as a genetic marker for NAFLD in Iranian patients with type 2 diabetes.
To determine whether the HFE gene variants H63D and C282Y are associated with NAFLD in persons with type 2 diabetes, we conducted a case-control study including 145 case of NAFLD patients with a history of type 2 diabetes and 145 matching control. The genomic DNA was extracted from the peripheral venous blood and the genotyping of HFE gene mutations was analyzed using the PCR-RFLP technique. Statistical analysis was performed using SPSS 12.0 software by χ2 test, t test and ANOVA (P<0.05). Data showed no increased frequency of HFE mutations in persons with type 2 diabetes and no association between H63D mutation and NAFLD in the study population. Also, we analyzed index of physiological variables including FBS, lipid profile (TC, TG, LDL-C, and HDL-C), BMI, HbA1c, and micro albuminuria and Cr levels). Data showed there are no relationship between these indexes and HFE gene mutations and either NAFLD as a complication of diabetes. But our results showed a relationship between C282Y mutation and NAFLD in persons with type 2 diabetes. C282Y mutation might be a genetic marker of NAFLD in Iranian population.
No takes yet. Share an insight, caveat, or question.
Saremi et al. (2016) conducted a case-control in Nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes (n=290). HFE gene mutations (H63D and C282Y) vs. Matched controls without NAFLD was evaluated on Association of HFE gene mutations with NAFLD. The C282Y mutation was associated with nonalcoholic fatty liver disease in Iranian patients with type 2 diabetes, whereas the H63D mutation showed no such association.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: